Derecki N.C., Cardani A.N., Yang C.H., Quinnies K.M., Crihfield A., Lynch K.R., Kipnis J. During its turn, neuronal damage contributes to the release of further proinflammatory cytokines by activated microglia. Kim T.S., Lim H.K., Lee J.Y., Kim D.J., Park S., Lee C., Lee C.U. Upon recognition of the Aβ peptides, infiltrating monocytes appear to differentiate into macrophages and to contribute to the clearance of Aβ from both the brain vasculature and parenchyma, thereby restricting Aβ plaques and reducing the degree of CAA [63,67]. Under these circumstances, it is indisputable that, to successfully fight this neurodegenerative disorder, we require accurate and sensitive diagnostic and prognostic tools to be used for implementing an early diagnosis, the monitoring of disease progression and assessing the treatment effectiveness. The resident innate immune cells of the brain are the principal players in neuroinflammation, and their activation leads to a defensive response aimed at promoting β-amyloid (Aβ) clearance. The inflammatory biomarker levels in plasma and cerebrospinal fluid (CSF) have been found to be altered in patients with VCID, indicating that neuroinflammation is involved in the pathogenesis of VCID . Interestingly, an increasing amount of data indicate that the gut microbiota may play a major role in priming “neuro”-inflammation and oxidative stress [82]. First of all, the biomarkers’ concentrations are likely to be considerably low compared to the CSF, as they undergo substantial dilutions when entering into the bloodstream; in addition, given the pathological heterogeneity of AD, the BBB integrity can be affected differently, with consequences on the degree of crossing analytes. Van Wetering S., van Buul J.D., Quik S., Mul F.P., Anthony E.C., ten Klooster J.P., Collard J.G., Hordijk P.L. In this review, we provide an overview on some of the most promising peripheral biomarkers of neuroinflammation, discussing their pathogenic role in AD. Regulation of learning and memory by meningeal immunity: A key role for IL-4. Sofroniew M.V., Vinters H.V. Foremost, neuroinflammation may compromise the blood-brain barrier (BBB) integrity, allowing the immune cells from the blood to penetrate the stroke brain. A selection of such targets is provided in this section, although, at the moment, none of them has a tangible clinical use. Alzheimer’s disease (AD), widely recognized as the most common cause of dementia, is an age-related neurodegenerative disorder characterized by progressive cognitive deterioration, affecting both memory and other aspects of cognitive functioning. government site. Peterson P.K., Hu S., Salak-Johnson J., Molitor T.W., Chao C.C. Neuroinflammation in Alzheimer’s disease. Introduction. Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress? Increased serum IL-1beta level in Alzheimer’s disease and mild cognitive impairment. Anti-Aβ antibodies have proven able to promote Aβ clearance, thereby reducing its deposition in plaques via different mechanisms; they can bind Aβ in the brain and favor its degradation by microglial cells [74] or facilitate its efflux through the BBB [75]; alternatively, they can sequester Aβ in the peripheral blood, lowering its free level, and induce its release from the brain (peripheral sink effect) [76]. Nevertheless, the existence of an immune–brain axis (see below, Section 3.2.1), the mechanism of inflammaging (Section 3.2.2) and the two-way relationship with delirium (Section 3.2.3) are just some of the evidence that changed our perception about a potential “peripheral” contribution to a central process. Kester M.I., Teunissen C.E., Sutphen C., Herries E.M., Ladenson J.H., Xiong C., Scheltens P., van der Flier W.M., Morris J.C., Holtzman D.M., et al. Soluble Fractalkine is a chemoattractant for NK cells predominantly expressed in the CNS by neurons and glial cells [145]. Delirium represents an extreme form of sickness behavior characterized by disturbances in multiple aspects of cognitive functioning ascribable to neuronal and synaptic dysfunctions [91]. Braestrup C., Albrechtsen R., Squires R.F. Dubois B., Villain N., Frisoni G.B., Rabinovici G.D., Sabbagh M., Cappa S., Bejanin A., Bombois S., Epelbaum S., Teichmann M., et al. Zheng D., Liwinski T., Elinav E. Interaction between microbiota and immunity in health and disease. Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer’s disease. Montagne A., Nation D.A., Sagare A.P., Barisano G., Sweeney M.D., Chakhoyan A., Pachicano M., Joe E., Nelson A.R., D’Orazio L.M., et al. Furthermore, higher baseline levels of CSF YKL-40 in preclinical and MCI patients are associated with an increased risk of progression to AD [161]. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model. In the AD brain, TREM2 is expressed by amyloid-associated microglia and peripherally recruited monocytes/macrophages [168,169,170]; upon binding oligomeric Aβ [171], it mediates the myeloid cell recruitment and accumulation around plaques [169,172], as well as amyloid uptake and degradation [173,174] (Figure 2). Nevertheless, these markers represent very interesting opportunities for a better understanding of AD pathogenesis, and in the future, they may form part of the panels for precision medicine, identifying selected patients for targeting drugs. In particular, in line with the hypothesized role in the early stage of the disease, higher MCP-1 concentrations were found, especially in MCI patients [137]. Nihonmatsu-Kikuchi N., Yu X.J., Matsuda Y., Ozawa N., Ito T., Satou K., Kaname T., Iwasaki Y., Akagi A., Yoshida M., et al. The existence of an intercommunication between the brain and the periphery is clearly supported by the occurrence of behavioral symptoms—a syndrome known as sickness behavior—in response to proinflammatory cytokines released in the framework of systemic inflammation [90]. Licensee MDPI, Basel, Switzerland. Alterations of the Neuroinflammatory Markers IL-6 and TRAIL in Alzheimer’s Disease. The neuroinflammation and infiltration of toxic aggregates lead to the dysfunction of these components, resulting in a homeostatic imbalance conceivably playing a role in the progression of AD [49]. Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: A meta-analysis and systematic review of 170 studies. Finally, the binding of ACh to α7 nicotinic acetylcholine receptors (α7nAChRs) expressed on macrophages inhibits proinflammatory cytokine synthesis and release, resulting in alleviated systemic inflammation [98] (Figure 1). Astrocytes accumulating around senile plaques are markedly hypertrophic and reactive, showing a striking upregulation of the glial fibrillary acidic protein (GFAP) [39,40]. and L.T. These mediators are produced by resident CNS glia (microglia and astrocytes), endothelial cells, and peripherally derived immune . 18,19 Such influx of inflammation-associated cytokines and chemokines mobilizes the innate immune microglial cells in the parenchyma, allows myeloid cell infiltration, and activates the . Interestingly, neuroinflammation is emerging as a common feature to target in most CNS pathologies. Inclusion in an NLM database does not imply endorsement of, or agreement with, However, the analysis of blood biomarkers comes with an array of detection challenges, imputable to the nature of the sample and to the complexity of AD pathology, and it could often be difficult to correlate the changes in the CNS with those observed in the blood. Wisniewski H.M., Wegiel J. Spatial relationships between astrocytes and classical plaque components. Citations: 616 Sections PDF Tools Share Abstract There is significant interest in understanding inflammatory responses within the brain and spinal cord. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer’s disease and associate with neuronal injury markers. Jay T.R., Miller C.M., Cheng P.J., Graham L.C., Bemiller S., Broihier M.L., Xu G., Margevicius D., Karlo J.C., Sousa G.L., et al. Does neuroinflammation fan the flame in neurodegenerative diseases? Neuroinflammation is defined as an inflammatory response within the brain or spinal cord. Rolyan H., Feike A.C., Upadhaya A.R., Waha A., Van Dooren T., Haass C., Birkenmeier G., Pietrzik C.U., Van Leuven F., Thal D.R. Wyss-Coray T., Lin C., Yan F., Yu G.Q., Rohde M., McConlogue L., Masliah E., Mucke L. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Furthermore, these naturally occurring anti-Aβ auto-antibodies (NAb) may have a role in preventing Aβ toxicity and aggregation [77,78]. The failure of microglial phagocytosis increases the amyloid burden in the brain and facilitates direct Aβ-induced neurotoxicity [35]. Additionally, the routine medical practice—based mostly on clinical and neuropsychological assessments in vivo—makes it possible to diagnose merely probable or possible AD [14]. Despite that the actual source of circulating cytokines has yet to be completely elucidated, assessing their peripheral profile could help shed light on the evolution of the inflammatory response throughout AD progression. This . Michelucci A., Heurtaux T., Grandbarbe L., Morga E., Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. ; collectively known as DAMP (danger-associated molecular patterns) and recognized by Toll-like receptors) are able to start such a response. However, the long-standing exposure to Aβ—due to its increased production and accumulation over time—and inflammatory mediators (a result of the proinflammatory environment) induce a functional impairment in the microglia, whose phagocytic capacity becomes largely insufficient [34]. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. This may be mainly due to the fact that these markers of immune system perturbation may indeed change in the blood following inflammatory events other than AD. Neuroinflammation refers to the process whereby the brain's innate immune system is triggered following an inflammatory. Furthermore, besides their role in maintaining the integrity of the NVU/BBB, oligodendrocyte progenitor cells may be a source of further Aβ secretion [54]. The current focus is primarily on blood, whose collection is a routine procedure undeniably less invasive, inexpensive, replicable at regular intervals and easy to implement in large populations compared to lumbar puncture. Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Sokolova A., Hill M.D., Rahimi F., Warden L.A., Halliday G.M., Shepherd C.E. Stalder A.K., Ermini F., Bondolfi L., Krenger W., Burbach G.J., Deller T., Coomaraswamy J., Staufenbiel M., Landmann R., Jucker M. Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice. Tournier B.B., Tsartsalis S., Ceyzériat K., Fraser B.H., Grégoire M.C., Kövari E., Millet P. Astrocytic TSPO Upregulation Appears Before Microglial TSPO in Alzheimer’s Disease. Lue L.F., Walker D.G. Galimberti D., Schoonenboom N., Scheltens P., Fenoglio C., Bouwman F., Venturelli E., Guidi I., Blankenstein M.A., Bresolin N., Scarpini E. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. and writing—review and editing, F.A., E.C., L.T., C.P.Z., F.D.R., I.A. Tönnies E., Trushina E. Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease. Further studies with novel sensitive techniques (e.g., Simoa) comparing the central and peripheral compartments are therefore advisable, analogously to what has been recently made, for example, for phosphorylated tau [194]. Morris J.C., Blennow K., Froelich L., Nordberg A., Soininen H., Waldemar G., Wahlund L.O., Dubois B. Harmonized diagnostic criteria for Alzheimer’s disease: Recommendations. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood–brain barrier model. Choi J., Lee H.W., Suk K. Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer’s disease. This research was funded by the Italian Ministry of Education, University and Research (MIUR), grant: PRIN 2017PFYK27 (AGAINST-AD) (L.T.). Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O’Garra A. IL-10 inhibits cytokine production by activated macrophages. 1. The adaptive immune system restrains Alzheimer’s disease pathogenesis by modulating microglial function. Hu J., Akama K.T., Krafft G.A., Chromy B.A., Van Eldik L.J. Heneka M.T., Carson M.J., El Khoury J., Landreth G.E., Brosseron F., Feinstein D.L., Jacobs A.H., Wyss-Coray T., Vitorica J., Ransohoff R.M., et al. Kim M.S., Kim Y., Choi H., Kim W., Park S., Lee D., Kim D.K., Kim H.J., Hyun D.W., Lee J.Y., et al. Histone deacetylases enzyme, copper, and IL-8 levels in patients with Alzheimer’s disease. Wu Y.Y., Hsu J.L., Wang H.C., Wu S.J., Hong C.J., Cheng I.H. They are ubiquitously distributed in the brain and act as the first line of defense, playing a fundamental role in its surveillance [29]. The https:// ensures that you are connecting to the Forlenza O.V., Diniz B.S., Talib L.L., Mendonça V.A., Ojopi E.B., Gattaz W.F., Teixeira A.L. Bugiani O. Introduction Inflammation is a response of the innate immune system that aims to protect and defend the body. Alzheimer’s disease is a synaptic failure. Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group. Inflammatory responses that are centralized within the brain and spinal cord are generally referred to as 'neuroinflammatory'. As a matter of fact, therapies currently administered to patients with more advanced diseases are just symptomatic and, thus, unable to block the pathophysiological events leading to full-blown AD. Secondly, it should be taken into account that AD can be accompanied by a systemic inflammatory response able to influence the blood levels of proteins indicative of the disease process; as a consequence, the fraction biomarkers attributable to the brain may be concealed by the one produced in the periphery. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression. Neuroinflammation is a pathological feature of a wide range of central nervous system (CNS) diseases, including classic neuroinflammatory disorders, such as multiple sclerosis (MS); neurodegenerative diseases, such as Alzheimer's disease (AD) and Huntington's disease (HD); disorders induced by brain injury; and neuropsychiatric disorders, such a. Antonell A., Mansilla A., Rami L., Lladó A., Iranzo A., Olives J., Balasa M., Sánchez-Valle R., Molinuevo J.L. FOIA Neuroinflammation is a cascade immune response mediated by innate immune-resident, CNS glial cells. The ideal biomarker for Alzheimer’s disease should closely reflect the succession of pathological events and prove potentially useful for a wide variety of applications. Vinters H.V. Hebert L.E., Bienias J.L., Aggarwal N.T., Wilson R.S., Bennett D.A., Shah R.C., Evans D.A. YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias. Exploration of neuroinflammatory pathways, immune-mediated mechanisms and the use of . To this end, the TSPO levels can be assessed using in vitro and in vivo imaging techniques with high selective tracers [187]. Söllvander S., Ekholm-Pettersson F., Brundin R.M., Westman G., Kilander L., Paulie S., Lannfelt L., Sehlin D. Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer’s Disease. Excessive triggering of the neuroinflammation can lead to persistent brain damage, such as disruption of blood-brain barrier (BBB) function, brain edema, neuronal apoptosis, and axial degeneration and loss [ 19 ]. Gispert J.D., Suárez-Calvet M., Monté G.C., Tucholka A., Falcon C., Rojas S., Rami L., Sánchez-Valle R., Lladó A., Kleinberger G., et al. Biomarkers for Alzheimer’s disease in plasma, serum and blood—Conceptual and practical problems. 2020; 153:104677. doi: 10.1016/j.phrs.2020.104677 Crossref Medline Google Scholar; 35. Chen M.K., Guilarte T.R. The evidence outlined above of an involvement of the peripheral immune system in AD pathogenesis inevitably offers the possibility of a theoretical approach to the blood compartment as a source of potential biomarkers. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer’s disease. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Sun Y.X., Minthon L., Wallmark A., Warkentin S., Blennow K., Janciauskiene S. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer’s disease. Despite being well-established that tau neurofibrillary tangles (NFT) and β-amyloid (Aβ) plaques are the hallmarks defining the neuropathology of this disease, it is not yet completely clear how much they contribute to neuronal degeneration spreading or if they may be just byproducts of ongoing damage [3]; this has been fully recognized and has led to the idea that other pathological processes can significantly contribute to AD pathogenesis as well [4]. Arranz A.M., De Strooper B. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model. Why is delirium more frequent in the elderly? Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease. Glial activation and inflammation along the Alzheimer’s disease continuum. Triggers can be an aseptic insult such as sterile surgery (where tissue damage caused by mechanical injury induces an inflammatory response), or non-aseptic (such as bacterial or viral invasion). Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. Zujovic V., Benavides J., Vigé X., Carter C., Taupin V. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. The contribution of circulating monocytes to AD pathogenesis is still controversial. official website and that any information you provide is encrypted Throughout AD progression, microglia switch from the M2 to M1 activation phenotype. Shimizu E., Kawahara K., Kajizono M., Sawada M., Nakayama H. IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1-42) by rat primary type 2 microglia. Likewise, the resident immune cells of the brain undergo a progressive shift toward a proinflammatory activated state with aging; the persistent stimulation over time makes them hypervigilant, enhancing their sensitivity and response to inflammatory stimuli (priming) [88]. 1. and transmitted securely. Neuroinflammation is a central feature in the development of AD—contributing to its pathogenesis just as much as Aβ plaques and NFT—and this may be especially relevant when thinking of the partial failure of anti-amyloid approaches. Abbott N.J., Rönnbäck L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Wong D., Dorovini-Zis K., Vincent S.R. Choi C., Jeong J.H., Jang J.S., Choi K., Lee J., Kwon J., Choi K.G., Lee J.S., Kang S.W. These symptoms allegedly reflect an exaggerated response of the CNS to systemic inflammatory stimuli due to the microglial priming [92] archetypal of advanced age and dementia, indeed recognized as the most common risk factors for delirium [93,94]. In addition, the number of B cells was found significantly increased in the blood of AD patients compared to healthy controls (given their role in antibody secretion, direct tissue infiltration is not necessarily required) [72]. Banks W.A., Kastin A.J., Broadwell R.D. Orre M., Kamphuis W., Osborn L.M., Jansen A.H.P., Kooijman L., Bossers K., Hol E.M. We found previously that treatment with exogenous naïve B cells was associated with structural and functional neurop. In any case, it should be noted that neuroinflammation priming is not a process specific for AD, since other protein aggregates (α-synuclein, TDP-43, etc. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Neuroinflammation is central to the common pathology of several acute and chronic brain diseases. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: Evidence for vagal mediation of immune-brain communication. Cytokines released by immunocompetent cells—whether they are peripheral immune cells or resident glial cells—promote the bidirectional crosstalk between the AD brain and the periphery. Defining "neuroinflammation" Neuroinflammation is a hot topic in contemporary neuroscience. In light of these premises, it is possible to speculate a protective role of TREM2 in the early stages of AD. The term neuroinflammation refers to the broad range of inflammatory responses that originate in the CNS secondary to insults, injury or disease. Wyss-Coray T., Loike J.D., Brionne T.C., Lu E., Anankov R., Yan F., Silverstein S.C., Husemann J. This may be counterintuitive at first, since AD is not a “classic” inflammatory disorder. Careers, Unable to load your collection due to an error. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. Daws M.R., Lanier L.L., Seaman W.E., Ryan J.C. Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Lunardelli M.L., Crupi R., Siracusa R., Cocuzza G., Cordaro M., Martini E., Impellizzeri D., Di Paola R., Cuzzocrea S. Co-ultraPEALut: Role in Preclinical and Clinical Delirium Manifestations.
DE 
EN